THE NAVAKIJ INSURANCE PUBLIC COMPANY LIMITEDSET: NKI🇹🇭 TH

Board Performance · 2025

Compliance Monitoring — Overview

Compliance Monitoring — Introduction

The Company places great importance on ensuring effective implementation of its corporate governance policies and practices. Appropriate mechanisms have been established to monitor compliance with such policies to ensure that business operations are conducted with transparency, efficiency, and in accordance with applicable laws, regulations, and recognized principles of good corporate governance.

The Board of Directors has assigned management and relevant functions to communicate, promote, and oversee the implementation of the Company’s corporate governance policies, code of conduct, and other key policies across the organization. Compliance with these policies is regularly monitored through key governance mechanisms, including the internal control system, risk management framework, internal audit function, and compliance processes. Significant findings and relevant issues are reported to management and the Board of Directors or relevant board committees, as appropriate, to ensure proper oversight and continuous improvement of the Company’s corporate governance practices.

Monitoring of Compliance with Other CG Policies & Guidelines

Compliance with Corporate Governance Policy, related policies and Code of Conduct

The Company has established a Corporate Governance Policy, related policies as well as Code of Conduct as a framework for conducting business with integrity, transparency, and in line with good corporate governance principles.

All directors, executives, and employees—representing 100 percent of the Company’s personnel—are required to study, acknowledge, and strictly adhere to the Code of Conduct. Executives at all levels are responsible for ensuring that employees under their supervision fully understand and comply with the established policies and guidelines.

The Company maintains mechanisms to monitor compliance with the Code of Conduct on an ongoing basis. In cases of non-compliance, responsible executives are required to review the underlying causes, implement appropriate corrective actions, and establish preventive measures to mitigate the risk of recurrence. The Company also closely monitors key compliance areas relevant to its business operations, including anti-money laundering, information and cybersecurity, as well as occupational health, safety, and working environment.

From a governance oversight perspective, the Compliance Department ensures that all business units operate in accordance with applicable laws and regulatory requirements, while the Internal Audit Department independently reviews operational practices across the organization. Both functions regularly report their findings to the Audit Committee.

During the past year, the Company did not identify any material violations of the Code of Conduct. In addition, there were no significant disputes with stakeholders or competitors, and no incidents of human rights violations related to the Company’s business operations were reported.

Prevention of Conflicts of Interest

Has the Company Acted to Prevent Conflicts of Interest?

Yes

Operations in the Past Year

The Company has established clear measures to prevent conflicts of interest. Employees are required to avoid any actions that may compete with the Company or involve self-dealing transactions that could give rise to conflicts of interest.

Directors, executives, and department heads are required to disclose their interests and those of their related persons. Such information is reviewed annually, while the list of related persons is reviewed on a quarterly basis to support the monitoring and verification of related party transactions to ensure transparency and compliance with applicable regulations. Details regarding the prevention of conflicts of interest are disclosed under Section 6.2 Business Code of Conduct, under "Prevention of conflicts of interest."

In 2025, the Board of Directors reviewed the Company’s conflict of interest policy and considered it to be adequate and appropriate. During the year, none of the Company’s directors or executives served as directors in companies with similar business operations to the Company, and no transactions that could potentially give rise to conflicts of interest were identified.

Number of Conflict-of-Interest Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to conflicts of interest (cases)000

Prevention of the Use of Inside Information

Has the Company Acted to Prevent the Use of Inside Information?

Yes

Operations in the Past Year

The Board of Directors has established a policy on the prevention of insider trading to prevent directors, executives, employees, and external parties who have access to the Company’s inside information, as well as their related persons, including spouses and minor children, from using undisclosed material information for personal gain or for the benefit of others. Any violation of such policy will be subject to disciplinary action in accordance with the Company’s regulations. Details of the policy are disclosed under Section 6.2 Business Code of Conduct, under “Prevention of misuse of inside information.”

During the year, the Board reviewed and revised the policy and considered it to be adequate and appropriate. Such policy was communicated to directors, executives, and employees to ensure proper understanding and compliance.

In 2025, directors and related persons who traded the Company’s securities duly reported changes in their securities holdings within the timeframe prescribed by law, and no trading occurred during the Company’s blackout period. The Board of Directors is regularly informed of changes in securities holdings of directors, executives, and related persons at Board meetings.

Number of Inside-Information Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to the use of inside information to seek benefits (cases)000

Anti-Corruption

Has the Company Acted on Anti-Corruption?

Yes

Operations in the Past Year

The Company declared its intention to participate in the Thai Private Sector Collective Action Against Corruption (CAC) on 26 July 2013. The Board of Directors has established an Anti-Corruption Policy to serve as a framework for conducting business with transparency, fairness, and in accordance with good corporate governance principles. Under this policy, directors, executives, and employees are strictly prohibited from engaging in or accepting any form of corruption, whether directly or indirectly.

In 2025, the Anti-Corruption Working Committee, appointed by the President, reviewed the Company’s anti-corruption policy and related measures to ensure alignment with CAC guidelines, applicable laws and regulations, as well as changes in the Company’s internal regulations and business environment. The revised policy was endorsed by the Remuneration, Nomination and Sustainability Development Committee prior to submission for approval by the Board of Directors.

The Company communicates the anti-corruption policy to directors, executives, and employees through the Company’s intranet and incorporates it into the orientation program for new employees. The policy is also communicated to suppliers, business partners, and associates through the Company’s website and other communication channels. Anti-corruption provisions are included in commercial agreements, and the Company encourages its business partners to participate in the CAC initiative.

Corruption risk is incorporated into the Company’s operational risk management framework. All departments are required to assess corruption-related risks and establish mitigation plans on an annual basis. The Risk Management Department monitors such risks and reports the results to the Risk Management Committee. During the past year, no incidents of corruption involving the Company’s directors, executives, or employees were identified.

The Company was first certified as a CAC member in 2015 and has maintained its certification through periodic recertification, with the most recent certification granted on 30 September 2024.

Details of the Anti-Corruption Policy and Measures are disclosed under Section 6.2 Business Code of Conduct, under “Anti-Corruption.”

Form of Anti-Corruption Operations

Operation
Review of appropriateness in anti-corruption
The participation in anti-corruption projects
Assessment and identification of corruption risk
Communication and training for employees on anti-corruption policy and guidelines

Number of Corruption Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to corruption (cases)000

Whistleblowing

Has the Company Implemented Whistleblowing Procedures?

Yes

Operations in the Past Year

The Company has established a Whistleblowing and Complaint Policy to provide stakeholders with appropriate channels to submit suggestions, complaints, or reports concerning suspected misconduct, fraud, violations of the Company’s policies, or other inappropriate conduct by directors, executives, or employees.

The Company has implemented secure and appropriate reporting channels, with due consideration given to the confidentiality of information and the protection of whistleblowers. All reports are handled in accordance with established procedures to ensure transparency, fairness, and independent review.

In 2025, the Company did not receive any complaint or whistleblowing report relating to violations of the Company’s corporate governance policies or practices.

Details of the Whistleblowing Policy are disclosed under Section 6.2 Business Code of Conduct, under “Whistleblowing and Protection of Whistleblowers.”

Number of Whistleblowing Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues received through whistleblowing channels (cases)000

Selection of Directors & Chief Executives

Selection, Development & Evaluation — Introduction

Nomination of Directors

The Remuneration, Nomination and Sustainability Development Committee is responsible for identifying and nominating individuals who possess appropriate qualifications, knowledge, expertise, and experience to serve as directors. The nomination process aims to ensure that the Board of Directors has a balanced and diverse composition, taking into account the knowledge, skills, experience, and professional expertise required for effective oversight of the Company’s business, in accordance with the Board Skills Matrix. The Company also promotes Board Diversity, including diversity in professional background, expertise, age, gender, and perspectives, to enhance the effectiveness of the Board’s governance and strategic decision-making.

In nominating directors, the Committee considers the overall structure, size, and composition of the Board, as well as Board Succession Planning, in order to maintain an appropriate balance of expertise and ensure continuity in the Company’s governance. The proposed candidates are then submitted to the Board of Directors for approval before being presented to the shareholders’ meeting for appointment.

The Company provides shareholders with the opportunity to nominate qualified individuals for election as directors in advance through the Company’s website. For the 2025 Annual General Meeting of Shareholders, shareholders were invited to submit nominations during the period from 15 October 2024 to 31 December 2024. However, no nominations were submitted.

The 2025 Annual General Meeting of Shareholders resolved to reappoint four directors who retired by rotation to serve another term, namely: General Montree Sungkasap, Mr. Nipol T. Jeerawong, Mr Anak Wanglee and Mr. Anin Wanglee. The election of directors was conducted by individual voting by shareholders.

Further details regarding the nomination policy and practices for directors are disclosed under Section 6.1.1: Policies and Practices Relating to the Board of Directors.

Directors & Chief Executives — Introduction

The Nomination, Remuneration and Sustainable Development Committee is responsible for overseeing a transparent nomination process to identify and screen qualified candidates with appropriate knowledge, competencies, and experience, as well as a sound understanding of the non-life insurance business. Candidates are selected based on a merit-based selection approach, taking into consideration their alignment with the Company’s business strategy and their capability to effectively lead and manage the organization, before being proposed to the Board of Directors for appointment as senior executives, namely the Chief Executive Officer and President.

In addition, the Committee reviews the structure and level of remuneration for senior executives, taking into account the Company’s operating performance, individual performance of the executives, and the appropriateness of the overall remuneration structure, prior to proposing the matter to the Board of Directors for approval.

In 2025, the Board of Directors approved the renewal of the employment contract of Mr. Pitipong Bisalputra as Chief Executive Officer and Managing Director, based on the results of his performance evaluation, the Company’s operating performance, and his demonstrated leadership capability in managing the organization. The performance evaluation of senior executives is conducted by non-executive directors to ensure transparency, objectivity, and independence in the assessment process.

Further details regarding the policy and procedures for the recruitment of senior executives are disclosed in Section 6.1.1 Board Policies and Practices under “Senior Executive Recruitment.”

Succession Planning

The Company places significant importance on succession planning for senior executives to ensure leadership continuity and to support the Company’s sustainable long-term growth. The Nomination, Remuneration and Sustainability Development Committee oversees the development of a leadership pipeline and regularly monitors the progress of the succession plan, reporting updates to the Board of Directors.

In 2025, the Company implemented leadership development initiatives for personnel identified in the Leadership Succession Plan for the position of President. Candidates within the succession pool were invited to present their organizational leadership vision and business plans to the Nomination, Remuneration and Sustainable Development Committee. These presentations were used to assess their leadership capability, leadership readiness, and strategic perspective in preparation for future executive roles.

The Committee subsequently summarized the assessment results and reported them to the Board of Directors to support the Board’s oversight and to ensure the continuity and sustainability of the Company’s leadership pipeline.

Are Directors Selected Through the Nomination Committee?

Yes

Are Chief Executives Selected Through the Nomination Committee?

Yes

Number of Directors from Major Shareholders

0

Rights of Minority Shareholders on Director Appointment

The Company places importance on the protection of shareholders’ rights and encourages the participation of minority shareholders in the corporate governance process. Minority shareholders are therefore given the opportunity to propose qualified candidates for consideration as directors of the Company in advance of the shareholders’ meeting, in accordance with the criteria and procedures prescribed by the Company and disclosed on the Company’s website.

For the 2025 Annual General Meeting of Shareholders, the Company invited minority shareholders to propose qualified candidates for nomination as directors during the period from 15 October to 31 December 2024. However, no minority shareholder proposed any candidate for consideration.

At the shareholders’ meeting, director nominees are proposed for election on an individual basis to enable shareholders to appropriately consider and exercise their voting rights. A nominee shall be elected as a director upon receiving more than half of the total votes of shareholders present and entitled to vote.

This practice is in line with the principles of good corporate governance and aims to promote transparency, fairness, and shareholder participation in the nomination and appointment of directors.

Method of Director Appointment

Method
Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights

Selection of Independent Directors

Criteria for Selecting Independent Directors

The Remuneration, Nomination and Sustainability Development Committee is responsible for considering and nominating qualified individuals for appointment as directors, particularly independent directors, in accordance with the criteria and procedures specified in the Nomination Policy for Directors and Senior Executives. The objective is to ensure that the Board of Directors has an appropriate composition, maintains independence, and is able to effectively perform its oversight responsibilities in line with good corporate governance principles.

As of 31 December 2025, the Board of Directors comprised five independent directors, all of whom possess qualifications and independence in accordance with the criteria prescribed by the Capital Market Supervisory Board. The key qualifications of independent directors are summarized as follows:

  1. Holding shares in the Company not exceeding 1 percent of the total voting shares of the Company, its parent company, subsidiaries, associated companies, major shareholders, or controlling persons, including shares held by related persons.

  2. Not being or having previously been a director involved in management, employee, staff member, salaried advisor, or controlling person of the Company, its parent company, subsidiaries, associated companies, companies within the same group, major shareholders, or controlling persons, unless having ceased such position for at least two years prior to appointment.

  3. Not having a relationship by blood or legal registration, including being a parent, spouse, sibling, or child, including the spouse of a child, of another director, executive, major shareholder, controlling person, or a person nominated to be a director, executive, or controlling person of the Company or its subsidiaries.

  4. Not having or having previously had a business relationship with the Company or related entities in a manner that may interfere with the exercise of independent judgment. Such relationship includes being a significant shareholder or controlling person of a party having business dealings with the Company, where the transaction value is THB 20 million or 3 percent of the Company’s Net Tangible Assets (NTA), whichever is lower, unless such relationship has ceased for at least two years prior to the appointment date. Business relationships include normal commercial transactions, property leasing, asset or service transactions, as well as financial assistance arrangements such as loans, guarantees, or collateral provision that may result in obligations between the Company and counterparties. In determining such obligations, transactions occurring within one year prior to the business relationship with the same person shall be aggregated.

  5. Not being or having previously been an auditor of the Company or related entities, and not being a significant shareholder, controlling person, or partner of an audit firm to which the Company’s auditor belongs, unless having ceased such relationship for at least two years prior to the appointment date.

  6. Not being or having previously been a professional service provider, including legal or financial advisors, receiving service fees exceeding THB 2 million per year from the Company or related entities, and not being a significant shareholder, controlling person, or partner of such service provider, unless having ceased such relationship for at least two years prior to appointment.

  7. Not being appointed as a director to represent the interests of the Company’s directors, major shareholders, or related persons of major shareholders.

  8. Not operating a business of the same nature that significantly competes with the Company or its subsidiaries, nor being a significant partner, executive director, employee, salaried advisor, or shareholder holding more than 1 percent of voting shares in a competing company.

  9. Not having any other characteristics that may impair the ability to express independent opinions regarding the Company’s operations.

The Board of Directors has established guidelines regarding business relationships involving independent directors to ensure that such directors can perform their duties objectively and independently. Under these guidelines, any business relationship eligible for consideration must not exceed 3 percent of the Company’s Net Tangible Assets (NTA) and must constitute normal business transactions or transactions supporting ordinary business operations under general commercial terms, without providing undue benefits to the independent director that could compromise independence.

To ensure transparency and oversight, the Company has established the following governance procedures:

  1. Management is responsible for reviewing and reporting any relevant business relationships of independent directors to the Board of Directors for consideration of their independence.

  2. Such business relationships must be disclosed when proposing the appointment of independent directors to the Board of Directors and the shareholders’ meeting.

  3. Relevant information must also be disclosed in the Form 56-1 One Report and other documents in accordance with the requirements of the Securities and Exchange Commission.

Did Any Independent Director Have a Business or Professional Relationship?

Yes

Nature of the Business Relationship or Professional Service

The Board of Directors has considered the business relationship between the Company and an automobile dealership and service center in which Mr. Kiat Srichomkwan, an independent director, is a major shareholder. In 2025, the total transaction value amounted to 17.48 million Baht, which does not exceed Baht 20 million and represents less than 3% of the Company’s net tangible assets (NTA).

Reasons for Maintaining or Appointing the Individual as an Independent Director

The Board of Directors considers that Mr. Kiet Srichomkwan possesses extensive experience and expertise in the automobile sales business, which is closely related to the Company’s motor insurance operations. His industry knowledge enables him to provide valuable perspectives and business insights that contribute to the Company’s oversight and business development.

In addition, his knowledge and professional experience align with the Board’s composition as reflected in the Board Skills Matrix, and further enhance the diversity of experience on the Board. The Board therefore considers it appropriate for Mr. Kiat Srijomkwan to continue serving as an independent director of the Company.

The Board's Opinion on the Individual's Role as an Independent Director

The Board considers that such transactions are normal business and supporting business transactions, conducted under commercial terms comparable to those offered to other business partners, and not subject to the determination or influence of Mr. Kiet Srichomkwan. The transactions comprise:

  1. Mr. Kiet Srichomkwan's own insurance premium, totaling 0.91 million Baht

  2. Insurance premiums under a vehicle sales promotion program provided by Toyota Motor Thailand Co., Ltd., whereby customers independently select their insurance provider, totaling 0.73 million Baht

  3. Automobile repair expenses for customers under the Toyota Care program and policies specifying repair at authorized service centers, totaling 15.82 million Baht.

The Board therefore considers that the transactions are immaterial relative to the Company’s business scale and conducted in the normal course of business on an arm’s length basis. Accordingly, they do not give rise to any material conflict of interest nor impair Mr. Kiat Srijomkwan’s ability to exercise independent judgement in performing his duties as an independent director, and he continues to meet the qualifications of an independent director as prescribed by the Capital Market Supervisory Board and relevant regulations.

Director Development

Director Development — Introduction

The Company places importance on the continuous development of the knowledge and capabilities of directors and executives to support the effective discharge of their corporate governance and management responsibilities, in alignment with the Company’s strategic direction and the evolving business environment. The Company therefore encourages directors and executives to attend training programs, seminars, and conferences relevant to their roles and responsibilities as well as good corporate governance practices, organized by external institutions such as the Thai Institute of Directors Association (IOD), regulatory authorities, and professional organizations. In addition, the Company promotes the continuous monitoring of developments and key issues relating to the non-life insurance industry and corporate governance practices.

In 2025, the Company’s directors and executives participated in training programs, seminars, and professional meetings relating to corporate governance, risk management, and business trends on an ongoing basis. Although the number of directors attending external training programs during the year was relatively limited, several directors possess extensive experience and long-standing expertise in the business and corporate governance, and were engaged in fulfilling their oversight responsibilities and Board meeting schedules during the period. Nevertheless, key insights and knowledge gained from such training and meetings were shared and discussed at Board meetings, ensuring that all directors remain informed of relevant developments and emerging trends.

The Company will continue to support and promote the ongoing development of directors’ knowledge and competencies, enabling the Board to perform its oversight duties effectively and in accordance with international standards of good corporate governance.

Qualifications for Director Selection — Introduction

As representatives of the shareholders, the Board of Directors plays a crucial role in overseeing and determining the strategic direction of the Company. The Board is responsible for establishing policies and strategies aimed at creating sustainable value for the Company, its shareholders, and all stakeholders, while driving the organization toward its vision of becoming a leading non-life insurance company. In doing so, the Company is committed to conducting its business with integrity, transparency, and ethical standards.

The Board of Directors is expected to demonstrate leadership, vision, and independence in exercising its judgment, while recognizing the importance of good corporate governance and corporate social responsibility, with the objective of maximizing the long-term interests of the Company and its shareholders as a whole. In this regard, the Company has established the qualifications of directors as follows:

Legal Qualifications
Directors must possess the qualifications and must not have any prohibited characteristics as prescribed by relevant laws and regulations, including the Public Limited Companies Act, the Securities and Exchange Act, the Non-Life Insurance Act, and other applicable laws. Directors must be persons who have reached legal age, are not bankrupt, incompetent, or quasi-incompetent, have never been finally convicted of an offense relating to property committed with dishonest intent, and have never been dismissed or removed from government service or a state organization on the grounds of dishonesty in the performance of duties.

Integrity and Ethical Conduct
Directors shall be persons of honesty and integrity, possessing sound moral character, ethics, responsibility, and maturity, and adhering to professional principles and standards in the conduct of their duties.

Independence in Judgment
Directors shall be able to exercise independent judgment in a transparent and fair manner, making decisions based on adequate information and reasonable grounds, and remaining independent from management and other interest groups.

Time Commitment
Directors shall be able to devote sufficient time and attention to the performance of their duties as directors to ensure that their responsibilities are carried out effectively.

Knowledge, Expertise, and Relevant Experience
Directors shall possess knowledge, expertise, and experience that are beneficial and aligned with the Company’s business strategy, including knowledge in the Company’s business operations, non-life insurance, organizational management, risk management, audit, internal control, finance and accounting, investment, and information technology.

Other Appropriate Qualifications
Directors shall possess any other qualifications as the Board of Directors may deem appropriate and beneficial to the governance and business operations of the Company.

Qualifications for Director Selection

QualificationSkill & Expertise
Directors should possess skills, knowledge, capabilities, and experience that are beneficial to the Company and aligned with its business strategy and operations.120 · Description: Insurance · 143 · Description: Accounting · 150 · Description: IT Management · 165 · Description: Risk Management · 166 · Description: Audit

Evaluation of Board & Subcommittee Performance

Criteria for Evaluating Board Performance

The Company places importance on the annual performance evaluation of the Board of Directors, Board Committees, and individual directors in order to assess Board Effectiveness and to promote the continuous improvement of the Company’s corporate governance practices. In 2025, the Company conducted performance evaluations of the following:

  1. The Board of Directors as a whole

  2. Individual directors

  3. The Audit Committee

  4. The Nomination, Remuneration and Sustainable Development Committee

Evaluation Criteria

The evaluation of the collective performance of the Board covers key aspects relating to the Board’s corporate governance responsibilities, including:

  1. Roles, structure, and qualifications of the Board

  2. Duties and responsibilities of the Board

  3. Effectiveness of Board meetings

  4. Directors’ performance in discharging their duties

  5. Relationship with and oversight of management

  6. Directors’ development and executive development

The individual director evaluation covers directors’ qualifications, their roles and responsibilities in corporate governance, as well as their participation in Board meetings and the appropriateness of their contributions and opinions during discussions.

Evaluation of Board Performance in the Past Year

The evaluation results indicate that the Board of Directors and Board Committees performed their duties effectively and in accordance with their governance roles. The Board actively provides strategic oversight, oversees risk management, and appropriately monitors management performance.

Directors exercise independent judgement and engage in constructive discussions at Board meetings. The Board is also able to provide constructive challenge to management, supporting sound strategic decision-making for the Company.

The Board has utilized the evaluation results to support continuous board improvement, with the aim of further strengthening Board Effectiveness and enhancing the Company’s corporate governance in line with international best practices.

Evaluation Results

Evaluated BodyGroup — Carried Out?Group — Grade / Average ScoreGroup — Grade / Full ScoreIndividual (Self-Assessment) — Carried Out?Individual (Self-Assessment) — Grade / Average ScoreIndividual (Self-Assessment) — Grade / Full ScoreCross (Assessing Other Directors) — Carried Out?
Board Of DirectorY93.22100Y96.33100N
Audit CommitteeY93.31100NN
Other SubcommitteeY96.03100NN

Subcommittees

Subcommittees

Results of the Subcommittee's Duty Performance

Attachment No. 8: The Risk Management Committee's Report

Attachment No. 9: The Investment Committee's Report

Attachment No. 7: The Remuneration, Nomination and Sustainable Development's Report

Attachment No. 11: The Product Governance Committee's Report

Meeting Attendance & Remuneration

Meeting Attendance — Sub-section Introduction

In 2025, the Company convened a total of seven Board of Directors’ meetings, comprising six Board meetings and one meeting of non-executive directors. For each meeting, a quorum was duly constituted with the attendance of not less than one-half of the total number of directors, in accordance with the Company’s Articles of Association.

Justification for Directors' Non-Attendance

Certain directors were unable to attend some meetings due to illness or urgent overseas commitments. Nevertheless, the directors concerned remained informed of the meeting matters and provided their input to management as appropriate, ensuring that the Company’s governance oversight continued to be carried out effectively.

Types of Remuneration of the Board of Directors

The Board of Directors determines the policy and structure of directors’ remuneration by taking into consideration the roles, responsibilities, scope of duties, and governance oversight of the directors. The remuneration framework is also benchmarked against other listed companies with comparable size and business characteristics. In addition, the Board considers the Company’s performance and the returns delivered to shareholders, such as dividends, in order to ensure that the remuneration level is appropriate, commensurate with responsibilities, and capable of attracting qualified individuals to serve as directors.

For 2025, the Annual General Meeting of Shareholders for the year 2024 approved the remuneration for directors and sub-committees as follows:

1. Monetary remuneration

1.1 Meeting allowances

The Company pays meeting allowances to directors and members of sub-committees only for meetings attended, at the following rates:

Board / Committee

Chairman (Baht/meeting)

Director (Baht/meeting)

Board of Directors

35,000

25,000

Audit Committee

35,000

25,000

Remuneration, Nomination and Sustainability Development Committee

25,000

15,000

Risk Management Committee

25,000

15,000

Investment Committee

25,000

15,000

1.2 Directors' bonus

In 2025, the Company did not pay directors’ bonuses as the Company reported an operating loss for the year. The Board of Directors therefore resolved to refrain from paying directors’ bonuses in order to align with the Company’s performance and taking into consideration the best interests of the Company and its shareholders.

2. Other remuneration

The Company does not provide any other remuneration or benefits to directors.

Remuneration or Benefits Payable to the Board

MetricAmount (Baht)
Remunerations or benefits pending payment to the board of directors over the past year (baht)0

Supervision of Subsidiaries & Associated Companies

Does the Company Have Subsidiaries or Associated Companies?

Yes

Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?

Yes

Mechanism for Overseeing Management of Subsidiaries

The Company has established appropriate guidelines for the governance of its associates by appointing the Company’s representatives to serve as directors in such associates in proportion to its shareholding. The appointed representatives are responsible for overseeing the management of the associates and safeguarding the Company’s interests. In performing their duties, such representatives are required to act with due care, prudence, and integrity, in accordance with the objectives and articles of association, resolutions of the Board of Directors and shareholders’ meetings, as well as the applicable laws and regulations governing the associates.

The Company’s representatives also participate in overseeing and monitoring the operations of the associates, including contributing to the determination of their strategic direction, policies, and business plans to ensure alignment with the Company’s overall business direction. They are responsible for reporting the performance and significant developments of the associates to the Company on a regular basis and for exercising their judgment in voting on matters presented to the board of directors of the associates in relation to the normal course of business operations.

In addition, the Company requires its associates to regularly disclose key information to the Company, including operating results, financial statements, and significant operational issues that may affect the associates’ performance. The Company also encourages associates to establish appropriate internal control systems, internal audit functions, compliance practices, and risk management frameworks that are commensurate with the size and complexity of their business operations.

Oversight Mechanisms

Mechanism
Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings
Disclosure of financial information and operating results
Transactions between the Company and related persons

Agreements Between the Company and Shareholders in Managing Subsidiaries

The Company has entered into a joint venture arrangement with other shareholders to jointly conduct business operations. The joint venture company does not have the authority to act on behalf of, or assume any obligations or liabilities for, any of the shareholders, either collectively or individually. The management of the joint venture company is overseen by its Board of Directors, which comprises six directors. Each shareholder has the right to appoint two directors to jointly determine policies, strategic direction, and oversee the operations of the joint venture company in accordance with its established objectives.

Board Duty Performance — Overview

Board Duty Performance — Overall Description

The Board of Directors is responsible for setting the Company’s policies, strategic direction, vision, mission, core values, and key operational targets. The Board also provides oversight of management to ensure that the Company operates in accordance with good corporate governance principles, conducts its business with integrity and transparency, and pursues sustainable growth. In performing its duties, the Board upholds accountability, ethical leadership, and long-term value creation for the Company, its shareholders, and all stakeholders.

In 2025, the Board reviewed the Company’s vision, mission, corporate governance policy, code of conduct, and the charters of the Board and its sub-committees to ensure alignment with the Corporate Governance Code for Listed Companies 2017 issued by the Securities and Exchange Commission (SEC), the Corporate Governance Report of Thai Listed Companies (CGR) assessment criteria of the Thai Institute of Directors Association (IOD), the Shareholders’ Meeting Quality Assessment Project guidelines of the Thai Investors Association, and the Notification of the Office of Insurance Commission regarding Corporate Governance of Non-Life Insurance Companies B.E. 2562 (2019).

The Board also oversaw management in formulating business strategies and plans that are aligned with the Company’s objectives, key strategic priorities, and sustainability goals. The strategic focus includes sustaining growth in the non-life insurance business, expanding distribution channels, developing products that address evolving customer needs, enhancing services through digital platforms, and improving operational efficiency through greater automation and technology adoption.

The Board’s performance during the year can be summarized in accordance with the principles of good corporate governance as follows:

Rights of Shareholders

The Board recognizes the importance of protecting shareholders’ fundamental rights and promotes shareholders’ participation in the Company’s governance and key decision-making processes.

The Company provided minority shareholders with the opportunity to propose agenda items for the 2025 Annual General Meeting of Shareholders and to nominate qualified candidates for election as directors during the period from 15 October 2024 to 31 December 2024. The criteria and procedures were disclosed through the Company’s website and the Stock Exchange of Thailand’s information disclosure system. No proposals or nominations were submitted during the specified period.

The 2025 Annual General Meeting of Shareholders was held on 24 April 2025 at the Glowfish Meeting Room, Sathorn Thani Building, North Sathorn Road, Bangkok, a venue conveniently accessible by public transportation and capable of accommodating shareholders appropriately.

The notice of the meeting, prepared in both Thai and English, together with the meeting agenda, the Board’s opinions, and supporting documents, was disclosed on the Company’s website on 20 March 2025, 34 days prior to the meeting date, to allow shareholders sufficient time to review the information and make informed decisions. During the meeting, the Chairman ensured that shareholders were given the opportunity to raise questions, express their views, and seek clarification on each agenda item prior to voting, thereby enabling shareholders to fully exercise their rights.

Equitable Treatment of Shareholders

The Company treats all shareholders fairly and equitably, including minority shareholders, and ensures that appropriate mechanisms are in place to facilitate the exercise of shareholders’ rights.

Shareholders were invited to submit questions in advance of the Annual General Meeting during the period from 20 March 2025 to 21 April 2025. No questions were submitted during this period.

For shareholders unable to attend the meeting in person, the Company provided Proxy Form B together with the meeting notice and proposed three independent directors to serve as proxy holders.

Registration for the meeting commenced two hours prior to the meeting, utilizing a barcode system to facilitate efficient registration while requiring only necessary documentation to minimize inconvenience to shareholders. All 13 directors attended the meeting, representing 100 percent attendance, together with executives, the external auditor, and the legal advisor who acted as the vote-counting inspector to ensure transparency, fairness, and compliance with applicable laws.

The Company reported the meeting resolutions through the Stock Exchange of Thailand’s information disclosure system on the same day and disclosed the minutes of the meeting within 13 days after the meeting date.

Role of Stakeholders

The Board recognizes the importance of stakeholders throughout the Company’s value chain and ensures that the Company conducts its business with due consideration for the rights and expectations of all stakeholder groups. Key stakeholder groups have been identified, and appropriate engagement approaches have been established to address their expectations and concerns.

The Company treats stakeholders fairly and communicates relevant information through various channels in both Thai and English to ensure timely and appropriate access to information.

The Company has also established a whistleblowing channel that enables stakeholders to report suspected misconduct or inappropriate practices in a confidential manner.

In 2025, the Company did not receive any complaints relating to non-compliance with the stakeholder engagement policy.

Disclosure and Transparency

The Board places strong emphasis on the timely, accurate, complete, and transparent disclosure of material information to ensure that shareholders and investors have equitable access to relevant information for decision-making.

The Company discloses information through the Stock Exchange of Thailand’s disclosure system, the Company’s website, and other communication channels in both Thai and English to facilitate convenient and equal access to information for investors and the public.

In 2025, the Company did not receive any order to revise its financial statements and was not subject to any regulatory action relating to the failure to disclose material information within the prescribed timeframe.

Responsibilities of the Board

The Board plays a critical role in providing leadership and oversight to ensure that the Company operates in line with its strategic objectives while maintaining strong governance and accountability. During the year, the Board reviewed the Company’s vision and mission and determined that they remained appropriate. The Board also approved the Company’s strategic direction, operational targets, and sustainability strategies for 2026, as proposed by management.

The Board ensures that the Company maintains an effective internal control system, risk management framework, and regulatory compliance process to support prudent and sustainable business operations.

The Company prepares its separate financial statements and consolidated financial statements with its associate at the end of each accounting period for submission to the shareholders’ meeting as required by law. These financial statements are prepared in accordance with applicable financial reporting standards and the formats prescribed by the Office of Insurance Commission.

The Board has assigned the Audit Committee to oversee the integrity and quality of financial reporting and to provide recommendations to the Board to ensure that the preparation of financial reports complies with applicable regulatory requirements.

The Board performs its duties with due care, prudence, and integrity. As a result, during the year the Company was not subject to any fines, accusations, or civil proceedings by regulatory authorities in relation to fraud or misconduct.

Audit Committee Duty Performance

Results of the Audit Committee's Duty Performance in the Past Year

Attachment No. 6: The Audit Committee's Report

Executive Committee Duty Performance

Results of the Executive Committee's Duty Performance in the Past Year

Attachment No. 10: The Executive Committee's Report

Contents